WisdomTree (WT) Stock Is Up, What You Need To Know

WisdomTree (WT) stock rose 2.9% after Goldman Sachs increased its price target to $21.30, citing improved earnings and industry outlook. Shares later settled at $24.40, up 1.5% from the previous close. WT has seen volatility, with 11 moves over 5% in the past year. The stock is up 95% YTD, near its 52-week high of $25.04.

Original reporting
Published Oct 2, 2026, 7:45 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 2, 2026, 9:16 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
WisdomTree (WT) Stock Is Up, What You Need To Know — source image
Decision brief

The 30-second read

$WTBullishMed
01

Why it matters

The price‑target increase signals confidence in earnings and industry outlook, likely prompting short‑term buying and supporting the recent price rally.

02

Market read

The upgrade provides a fresh catalyst for WT, making the stock a short‑term buying candidate.

03

What to watch

Potential headwinds from higher interest rates could dampen asset‑management inflows despite the upgrade.

Relevance 7/10Novelty 7/10Timing: afternoon session today

Background

WisdomTree is a publicly traded asset‑management firm known for ETFs and index products. Analyst upgrades can materially affect its valuation.

Company-level read

Ticker impact

$WTBullishHigh confidence
Context

Goldman Sachs raised its price target on WisdomTree to $21.30, prompting a 2.9% jump in the stock during the afternoon session.

Expected impact

upward pressure as the market prices in the higher target and improved earnings outlook

Evidence & confidence

Target raises from a major bank are strong buy‑side signals; the stock already reacted positively, suggesting continued demand.

Market effects

The upgrade may lift sentiment across the asset‑management sector, especially other fee‑based ETFs and index providers.

Primarily U.S. equity markets; no immediate global ripple.

Limited to investors tracking U.S. listed asset‑management stocks.

Counterpoint

Some traders may view the modest price rise as already priced in, preferring to wait for further earnings data.

Key entities

  • Goldman Sachs

    Raised WisdomTree price target to $21.30.

  • WisdomTree

    Asset‑management firm whose shares rose 2.9% after the upgrade.

Related articles

$WTMed

WT Maintained by Craig-Hallum -- Price Target Raised to $29.00

Craig-Hallum raised its price target for WisdomTree (WT) to $29.00 from $24.00, maintaining a 'Buy' rating. The stock is currently priced at $24.73, which GuruFocus deems 40.1% overvalued. WT has a GF Score™ of 82/100, showing strong performance but concerns over valuation. Insiders have sold $736,800 in shares recently, with no purchases.

$WTMed

WT Maintained by Goldman Sachs -- Price Target Raised to $21.30

Goldman Sachs maintained a Neutral rating on WisdomTree (WT) but raised its price target to $21.30 from $18.30. GuruFocus values WT at $17.65, suggesting a 41% overvaluation. The company has a GF Score of 82/100, with strong profitability and growth but low valuation metrics. Insiders have sold $736,800 worth of shares in the last three months.

$WTMed

Should You Buy WisdomTree (WT) Stock After Its Latest Crypto Move?

WisdomTree (WT) reported record AUM of $162.9B in Q2 2026, up 30% YoY, with revenue at $177.2M and 40.5% operating margin. The company partnered with MoonPay to integrate its tokenized fund WTGXX, accessing 35M accounts. Despite GAAP losses from debt repurchases, management highlights long-term growth potential in digital assets. WT trades at a forward P/E of 17.30.

$WTMed

WisdomTree Announces Second Quarter 2026 Results

WisdomTree, Inc. (WT) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 WisdomTree Announces Second Quarter 2026 Results Record AUM of $162.9 Billion Diluted Earnings Per Share of $0.28; Adjusted Earnings Per Share of $0.31 13% Annualized Organic Flow Growth Rate Operating Margin Expanded by 780 bps Year over Year; or 900 bps, on an Adju

$WTMed

WisdomTree (NYSE:WT) Delivers Strong Q2 CY2026 Numbers

Asset management firm WisdomTree (NYSE: WT) beat Wall Street’s revenue expectations in Q2 CY2026, with sales up 57.3% year on year to $177.2 million. Its non-GAAP profit of $0.31 per share was 17.3% above analysts’ consensus estimates. Is now the time to buy WisdomTree? Find out by accessing our full research report, it’s free. "The second quarter demonstrated the quality of WisdomTree's growth.

$WTMedAI 8/10

WisdomTree (WT) Launches Physical AI, Humanoids, Drones ETF (WDRN) Focused on Real-World Automation

WisdomTree (NYSE:WT) launched the Physical AI, Humanoids, and Drones ETF (WDRN) on May 14, targeting companies applying AI to physical tasks. The fund has a 0.45% expense ratio and focuses on humanoid robotics, autonomous drones, smart manufacturing, and logistics automation, using a rules-based, quarterly rebalanced index. The report says it aims to track the shift from digital AI to real-world automation.